Strikingly, we did not find an association of HMGA2 expression levels with survival in oxaliplatin-treated colon cancer patients, while we initially identified HMGA2 because it was differentially regulated between XPCoxa-active and inactive cells. The gene discussed is HMGA2; the disease is malignant colon neoplasm.